Kirk Depriest, DO
Pulmonary Disease · Fort Collins, CONPI 1790993699
Payments from drug & device makers
Across 62 payments — averaging $170.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Pulmonx Corporation$865
- Olympus Corporation Of The Americas$751
- Medtronic$275
- Inari Medical, Inc.$138
- Focal Therapeutics, Inc.$135
- plus $351 from 7 others
What the payments were for
- Speaking & faculty fees$5005%
- Travel & lodging$1,52614%
- Food & beverage$2,95428%
- Education$5,55353%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 25 | $8,026 |
| Pulmonx Corporation | 11 | $865 |
| Olympus Corporation Of The Americas | 10 | $751 |
| Medtronic | 4 | $275 |
| Inari Medical, Inc. | 1 | $138 |
| Focal Therapeutics, Inc. | 1 | $135 |
| ZOLL Respicardia, Inc. | 1 | $128 |
| Davol Inc. | 2 | $59 |
| Insmed, Inc. | 3 | $52 |
| Covidien LP | 1 | $44 |
| Innovation Technologies Inc | 1 | $40 |
| United Therapeutics Corporation | 1 | $19 |
| Veran Medical Technologies, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,495
- CHARTIS CATHETER$734
- ZEPHYR DELIVERY CATHETER$734
- ZEPHYR ENDOBRONCHIAL VALVE$734
- PULMONX CHARTIS TABLET CONSOLE$734
- Olympus Bronchoscopes$619
- Olympus Capital Accessories$619
- Olympus Respiratory Accessories$619
- FLOWTRIEVER CATHETER, S$138
- CT THROMBECTOMY SYSTEM KIT$138
- Localizer$135
- ILLUMISITE$130
- remede System$128
How this compares
$10,541 in reported general payments places this provider in the 70th percentile of 248 pulmonary disease providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 12 | $240,197 |
| OfevNintedanib Esylate | 19 | $236,625 |
| XyremSodium Oxybate | 12 | $172,133 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 78 | $69,491 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 48 | $52,461 |
| Spiriva RespimatTiotropium Bromide | 45 | $43,252 |
| Breo ElliptaFluticasone/Vilanterol | 50 | $34,847 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 44 | $21,267 |
| Spiriva HandihalerTiotropium Bromide | 12 | $17,544 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $16,053 |
| Incruse ElliptaUmeclidinium Bromide | 21 | $11,291 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $9,103 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 27 | $7,311 |
| Sildenafil Citrate | 11 | $4,512 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 92 | $3,696 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Fort Collins
- Mark NeagleFort Collins$314K
- David SchwartzAurora$6.7M
- Michael WechslerDenver$3.6M
- David BadeschAurora$2.2M
- Jennifer Taylor CousarDenver$1.4M
- Evans Fernandez PerezDenver$1.3M
- Ronald BalkissoonDenver$1.2M
- Jeffrey SwigrisDenver$845K
- Joshua SolomonDenver$705K
- Thomas WilcoxBoulder$698K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.